Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

Mar 04, 2020

|

NEW YORK — The Pulmonary Fibrosis Foundation (PFF) said on Wednesday that it has partnered with Bristol-Myers Squibb subsidiary Celgene to launch a research consortium to identify biomarkers of pulmonary fibrosis that can guide therapy.

The foundation noted that the biomarkers would be directed at the development of treatments for patients with idiopathic pulmonary fibrosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Slow Release of Viral Sequence

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

Journals Raise Concerns Over Data Source

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports.

Details From a Short Life

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

Genome Research Papers on Brain Expression, Inversion Assay, Polymorphic Yeast Centromeres

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.

Featured White Papers

NGS-Based Target Capture for SARS-CoV-2 Detection and Characterization

Best Practices for Point of Care (POC) Product Development

Seeing Beyond the Limit: Detect Residual Disease and Assess Treatment Response

A Personalized, Tumor-Informed Approach to Detect Molecular Residual Disease With High Sensitivity and Specificity

Jun

04

Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.

Jul

15

Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Menu

Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

To read the full story....

Breaking News

Sperm Single Cell Sequencing Study Offers Insight Into Meiotic Variation

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

OpGen Expands Partnership with New York State Department of Health to Detect AMR Infections

OraSure Technologies Prices $82.5M Stock Offering

PharmaFluidics Wins €613K Grant From Flemish Government

NuProbe Licenses Two Oligonucleotide Technologies from Rice University

The Scan

Slow Release of Viral Sequence

Journals Raise Concerns Over Data Source

Details From a Short Life

Genome Research Papers on Brain Expression, Inversion Assay, Polymorphic Yeast Centromeres

Featured White Papers

COVID-19 Testing, Treatment and Future Outlook

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Guardant Health Prices $315M Public Offering

Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

Sponsorships